Stock futures are little changed after S&P 500 posts another record close: Live updates
Angela Weiss | AFP | Getty Images
Stock futures were little changed on Monday night after the S&P 500 and Nasdaq Composite hit fresh records.
Futures tied to the Dow Jones Industrial Average 59 points, or 0.1%. S&P 500 futures added 0.06%, while Nasdaq 100 futures gained 0.03%.
Shares of NXP Semiconductors lost more than 5% in extended trading after the company reported a decline in second-quarter revenue, weighed down by weakness in the automotive market.
Stocks are starting the week off strong. The S&P 500 in the previous session rose about 0.1% and ended the session at 6,305.60, marking the index's first close above the 6,300 level. A rally in tech stocks ahead of quarterly results for key megacap names boosted the Nasdaq Composite by nearly 0.4% for a closing record of 20,974.17. Both indexes hit new all-time intraday highs earlier in the session. The Dow underperformed and ended the day marginally lower.
Investors are now turning to a big week for second-quarter financial results. So far, more than 60 S&P 500 companies have reported, with more than 85% of those topping analysts' estimates, according to FactSet data. Eyes are on commentary from companies about macroeconomic certainty, the impact of tariffs and details on demand and spending related to artificial intelligence.
Philip Morris International, Coca-Cola and Lockheed Martin are just a few of the companies on deck to report earnings results on Tuesday. Google parent Alphabet and Tesla will report Wednesday, kicking off highly anticipated results from the "Magnificent Seven" companies. The mega-cap tech companies are expected to contribute to a significant amount of earnings growth this season.
Given the recent rally in stocks, investors are watching for how far the market can run, with some commenting that valuations already appear stretched. Cetera Investment Management chief investment officer Gene Goldman said that "much of the good news appears to be priced in, leaving little margin for error."
"Markets may have rallied too far, too fast," Goldman added. "After dipping after 'liberation day' to 4,982, the S&P bounced back sharply, in fact – the recovery has been the fastest in nearly 50 years even as 2025 earnings expectations were nearly halved."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Revvity (RVTY) Stock Is Falling Today
What Happened? Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its full-year profit forecast, which overshadowed its second-quarter earnings and revenue beat. Despite reporting second-quarter revenue of $720 million and an adjusted earnings per share (EPS) of $1.18, both of which surpassed analyst expectations, investors focused on the weaker outlook. Revvity trimmed its full-year adjusted EPS guidance to a range of $4.85 to $4.95. This revision was driven by multiple headwinds, including a double-digit decline in its diagnostics revenue from China, a key international market. The company also faced shrinking profitability, as both its adjusted operating and gross margins fell compared to the previous year. Management also pointed to potential costs related to tariffs. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Revvity? Access our full analysis report here, it's free. What Is The Market Telling Us Revvity's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 10 days ago when the stock dropped 3.2% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Revvity is down 14.7% since the beginning of the year, and at $95.58 per share, it is trading 25.2% below its 52-week high of $127.75 from September 2024. Investors who bought $1,000 worth of Revvity's shares 5 years ago would now be looking at an investment worth $845.92. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Why Xponential Fitness (XPOF) Stock Is Trading Up Today
What Happened? Shares of boutique fitness studio franchisor Xponential Fitness (NYSE:XPOF) jumped 3.4% in the pre-market session after the company announced it had completed the divestiture of its CycleBar and Rumble brands. The fitness franchisor sold the two brands to Extraordinary Brands, LLC, as part of a strategic realignment. Xponential Fitness stated that the transaction was consistent with its plan to focus resources and capital on its more profitable brands. In a statement, CEO Mark King emphasized that the company would concentrate on brands that drove both current and long-term profitability. This move was presented as a strategic effort to improve the company's financial performance and provide better support for its core, higher-performing franchises. After the initial pop the shares cooled down to $11.01, up 2.3% from previous close. Is now the time to buy Xponential Fitness? Access our full analysis report here, it's free. What Is The Market Telling Us Xponential Fitness's shares are extremely volatile and have had 50 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 25 days ago when the stock gained 34.1% on the news that the company announced that the U.S. Securities and Exchange Commission (SEC) has concluded its investigation into the company without recommending any enforcement action. The investigation, which began in December 2023, had been a significant overhang on the company's stock, which has fallen approximately 45% year-to-date. The probe was initiated after the SEC requested documents related to potential securities fraud and accounting issues. In a filing, Xponential stated it was informed on July 1 that the investigation was concluded and that no action would be taken. The company noted it had fully cooperated with the regulator over the past 18 months. This news removed a major cloud of uncertainty for investors, leading to a surge in confidence as reflected in the pre-market rally. Analysts at Jefferies noted that with the probe now cleared and new leadership in place, investor sentiment should improve, potentially allowing the stock's valuation to rise toward peer levels as the company focuses on its growth plans. Xponential Fitness is down 21.1% since the beginning of the year, and at $11.01 per share, it is trading 40.4% below its 52-week high of $18.47 from February 2025. Investors who bought $1,000 worth of Xponential Fitness's shares at the IPO in July 2021 would now be looking at an investment worth $898.78. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
CNBC
24 minutes ago
- CNBC
Stocks slip despite EU trade deal — plus, the 2 questions we want tech earnings to answer
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are relatively muted on Monday, with the S & P 500 giving up modest earlier gains and turning lower. If the broad index squeezes out a gain Monday, it would mark its sixth straight positive session and another record close. Monday's action could be described as the calm before the storm. Over the next few days, the market is going to digest a slew of major headlines , including earnings reports from about one-third of the S & P 500, a Federal Reserve policy announcement, and the July nonfarm payrolls report. As we look ahead to this week's earnings reports from the leading AI hyperscalers — Club names Meta Platforms , Microsoft , and Amazon — our focus will be on answering two questions. The first: Does revenue growth justify the elevated levels of spending? Secondly, will full-year capital expenditure outlooks, particularly for AI infrastructure investments, be increased due to robust long-term demand signals? Last week, we heard from Google parent Alphabet that it was upping its capex guide for 2025 to $85 billion, an increase of $10 billion from prior guidance. Trade talk : The news flow surrounding the Trump administration's Friday tariff deadline remains positive—or, at the very least, free of setbacks — as the U.S. and European Union reached an agreement over the weekend. Tariffs on goods imported to the United States are here to stay, likely in the 15% to 20% range, according to President Donald Trump. But on the flip side, trade deals are opening up market access for U.S. exporters and reducing the risk of sudden escalations that can drive supply chains crazy. Up next: Some notable companies reporting after the closing bell on Monday are Celestica , Waste Management , Cadence Design Systems , Whirlpool , and Veralto . Before the opening bell on Tuesday, we'll hear from Boeing , UnitedHealth Group , SoFi , PayPal , United Parcel Service , Spotify , Merck , Nucor , Procter & Gamble , and Carrier . On the data side, there's JOLTS Job Openings and the Conference Board Consumer Confidence index. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
